Skip to main content
. 2018 Jun 1;7(6):359–369. doi: 10.1159/000489018

Table 4.

Re-VRD PED salvage therapy case summaries

Case No. History Size, mm Location Type Previous Txs, n Previous stent Interval since latest stent, months PEDs used, n Clinical follow-up, months Time from retreatment to follow-up DSA, months Occlusion on latest follow-up Complications
12 diplopia 20 ICA, cavernous Sac 1 neuroform stent-coil 3 13.5 13.5 complete no
13 trauma 18 ICA, cavernous Diss 1 wall-stent, coil 155.2 3 14.0 5.8 entry remnant no
14 h/o SAH 12 vertebral, V4 Diss 1 coronary stent 128.2 1 10.4 7.3 total filling no
15 pupillary dilatation, ptosis & proptosis 25 ICA, cavernous Sac 1 neuroform stent-coil 116.5 2 0.6 no
16 Inc 4 ICA, ophthalmic Sac 1 neuroform stent-coil 110.1 1 9.0 no
17 Inc 10 ICA, supraclinoid Sac 2 neuroform stent-coil 103.4 3 13.8 7.1 complete no
18 h/o SAH 17 ICA, ophthalmic Sac 3 enterprise stent-coil 45.2 1 11.2 11.2 complete asymptomatic proximal ICA occlusion
19 Inc 25 vertebral, VBJ Fus 4 neuroform stent, PED 32.9 1 8.8 5.6 subtotal filling no
20 h/o SAH 12 vertebral, V4 Diss 2 coronary stent, PED 8.3 2 6.0 6.0 complete no

VRD, vascular reconstruction device; PED, Pipeline embolization device; DSA, digital subtraction angiography; ICA, internal carotid artery; Inc, incidental; h/o SAH, history of subarachnoid hemorrhage; Sac, saccular; Fus, fusiform; Diss, dissecting.